Sitemap
October 05, 2009 Articles
Filter by Available Specialty
- Allergan sues to share safety information about off-label use of Botox
- Anti-VEGF therapy may offer promise for patients with pigment epithelium detachment secondary to AMD
- Fewer than half of graduating medical students say they understand the health care system
- Glucose variability not a risk factor for neuropathy
- Hot flashes may be marker of CVD risk
- Inhibition of VEGF may be beneficial for treatment of retinopathy of prematurity
- Owning an ophthalmology practice is now far more complex
- Phase 3 CRUISE study suggests safety, efficacy of VEGF therapy in central retinal vein occlusion
- PVL linked with heightened S. aureus disease severity in children
- PVL linked with heightened S. aureus disease severity in children
- RATIO study: Lupus anticoagulant risk factor for arterial thrombotic events
- Search for optimal anti-VEGF dosing strategy in AMD continues